Effects of Janus Kinase Inhibitor tofacitinib on circulating serum amyloid A and interlukin-6 during treatment for rheumatoid arthritis
Clinical and Experimental Immunology doi.10.1111/cei.12234
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Clinical and Experimental Immunology doi.10.1111/cei.12234
. ARD published online first 13 Feb 2014. Doi: 10.1136/annrheumdis-2013-204105
Tissue Engineering Part A doi:10/1089/ten.TEA.2013.0553
Basic Clin Pharmacol Toxicol. 2013 Oct 24. doi: 10.1111/bcpt.12164
Pharmacological Research 2013; 76:1–8
Journal of Immunology 2013;191:3568–77
Ann Rheum Dis 2013. doi: 10.1136/annrheumdis-2013-203756
Clin Exp Immunol. 2013 Aug 23. doi: 10.1111/cei.12190
International Journal of Clinical Rheumatology June 2013; 8(3):311–13
Rheumatology 2013: doi: 10.1093/rheumatology/kes417